Breaking News

Axcan To Acquire Eurand

Axcan Holdings will acquire all outstanding shares of Eurand for approximately $583 million in cash.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Axcan Holdings will acquire all outstanding shares of Eurand for approximately $583 million in cash. The combined company will be led by Axcan’s president and chief executive officer, Frank Verwiel, M.D. The transaction is expected to close in 2Q11. Angelo C. Malahias, chairman of Eurand’s Special Committee, said, “After an extended auction process, and in conjunction with its independent financial and legal advisors, the board of directors has concluded that this agreement is in ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters